Literature DB >> 14634459

Involvement of nitric oxide and hyperbaric oxygen in the pathogenesis of cyclophosphamide induced hemorrhagic cystitis in rats.

Ahmet Korkmaz1, Sukru Oter, Salih Deveci, Taner Ozgurtas, Turgut Topal, Serdar Sadir, Hayati Bilgic.   

Abstract

PURPOSE: We evaluated the relationship between nitric oxide and hyperbaric oxygenation in the pathogenesis and treatment of cyclophosphamide induced hemorrhagic cystitis in rats.
MATERIALS AND METHODS: Cyclophosphamide (100 mg/kg) was injected in male Sprague-Dawley rats for cystitis induction. Animals were treated before and the day after cyclophosphamide injection with 100 mg/kg of the nitric oxide substrate L-arginine, 20 mg/kg of the nonselective nitric oxide synthase inhibitor L-NG-nitroarginine methyl ester and 20 mg/kg of the selective inducible nitric oxide synthase inhibitor S-methylisothiourea. Animals were exposed to hyperbaric oxygen (2.8 atmospheres absolute for 90 minutes twice daily) with or without the administration of L-arginine and nitric oxide synthase inhibitors.
RESULTS: Cyclophosphamide injection resulted in severe cystitis. S-methylisothiourea produced marked inhibition of cyclophosphamide induced bladder tissue damage. L-arginine and L-NG-nitroarginine methyl ester failed to a show meaningful protective effect. Hyperbaric oxygen protected the bladder only against ulceration. Moreover, hyperbaric oxygen did not contribute to the protective effects of L-arginine, L-NG-nitroarginine methyl ester or S-methylisothiourea.
CONCLUSIONS: Nitric oxide produced by inducible nitric oxide synthase is an important mediator in the pathogenesis of cyclophosphamide induced cystitis. Hyperbaric oxygen has a beneficial effect on repairing bladder damage rather than on bladder protection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14634459     DOI: 10.1097/01.ju.0000085593.31396.d8

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  10 in total

1.  Uroprotective effect of pantoprazole against cyclophosphamide-induced cystitis in mice.

Authors:  Seckin Engin; Elif Nur Barut; Burak Barut; Mine Kadioglu Duman; Cansu Kaya; Gokcen Kerimoglu; Arzu Ozel
Journal:  Support Care Cancer       Date:  2019-03-14       Impact factor: 3.603

2.  Hyperbaric oxygen enhances the efficiency of 5-aminosalicylic acid in acetic acid-induced colitis in rats.

Authors:  Semih Gorgulu; Gokhan Yagci; Nihat Kaymakcioglu; Murat Ozkara; Bulent Kurt; Ayhan Ozcan; Omer Kaya; Serdar Sadir; Turgut Tufan
Journal:  Dig Dis Sci       Date:  2006-03       Impact factor: 3.199

3.  Effects of hyperbaric oxygen treatment on liver functions, oxidative status and histology in septic rats.

Authors:  Sukru Oter; Mustafa Edremitlioglu; Ahmet Korkmaz; Omer Coskun; Dilek Kilic; Ucler Kisa; Hakan Yaren; Hayati Bilgic
Journal:  Intensive Care Med       Date:  2005-07-21       Impact factor: 17.440

4.  Hyperbaric oxygen treatment for refractory haemorrhagic cystitis occurring after chemotherapy and haematopoietic stem cell transplantation: retrospective analysis of 25 patients.

Authors:  Handan Ozturk; Bengusu Mirasoglu; Samil Aktas
Journal:  Diving Hyperb Med       Date:  2022-03-31       Impact factor: 1.228

5.  Epigenetic perturbations in the pathogenesis of mustard toxicity; hypothesis and preliminary results.

Authors:  Ahmet Korkmaz; Hakan Yaren; Z Ilker Kunak; Bulent Uysal; Bulent Kurt; Turgut Topal; Levent Kenar; Ergun Ucar; Sukru Oter
Journal:  Interdiscip Toxicol       Date:  2008-12

6.  Acute and delayed sulfur mustard toxicity; novel mechanisms and future studies.

Authors:  Ahmet Korkmaz; Dun-Xian Tan; Russel J Reiter
Journal:  Interdiscip Toxicol       Date:  2008-06

7.  Ozone therapy and hyperbaric oxygen treatment in lung injury in septic rats.

Authors:  Levent Yamanel; Umit Kaldirim; Yesim Oztas; Omer Coskun; Yavuz Poyrazoglu; Murat Durusu; Tuncer Cayci; Ahmet Ozturk; Seref Demirbas; Mehmet Yasar; Orhan Cinar; Salim Kemal Tuncer; Yusuf Emrah Eyi; Bulent Uysal; Turgut Topal; Sukru Oter; Ahmet Korkmaz
Journal:  Int J Med Sci       Date:  2011-01-03       Impact factor: 3.738

8.  Intravesical Administration of Xenogeneic Porcine Urothelial Cells Attenuates Cyclophosphamide-Induced Cystitis in Mice.

Authors:  Chi-Ping Huang; Chi-Cheng Chen; Yi-Tung Tsai; Chun-Chie Wu; Chih-Rong Shyr
Journal:  Cell Transplant       Date:  2019-01-24       Impact factor: 4.064

9.  Diallyl Disulfide Prevents Cyclophosphamide-Induced Hemorrhagic Cystitis in Rats through the Inhibition of Oxidative Damage, MAPKs, and NF-κB Pathways.

Authors:  Sung Hwan Kim; In Chul Lee; Je Won Ko; Changjong Moon; Sung Ho Kim; In Sik Shin; Young Won Seo; Hyoung Chin Kim; Jong Choon Kim
Journal:  Biomol Ther (Seoul)       Date:  2015-03-01       Impact factor: 4.634

10.  Adjuvant treatment with adipose-derived mesenchymal stem cells (ADSC) reduces severe refractory hemorrhagic cystitis after RIC-PBSCT: A case report.

Authors:  Ruixue Yang; Gang Chen; Maria Muhashi; Gulibadanmu Aizezi; Ming Jiang; Hailong Yuan
Journal:  Medicine (Baltimore)       Date:  2021-07-02       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.